Kiran Mazumdar-Shaw shares with Catherine Jewell, her story of innovation and entrepreneurship; Her journey from brewing to creating Biocon, Asia's leading Biopharmaceutical Company.
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, [...]
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced [...]
To download the complete article, visit: http://bit.ly/2ncVkXM
There are nearly half a billion diabetes patients in the world. The alarming growth in the global diabetes population is leading to a huge demand for effective therapies from pre/early diabetes to late-stage disease. Of the 100 million people who need insulin globally, however, only ‘one in two’ can manage and afford costs associated with [...]
The highest attainable standard of health is a fundamental right of every human being. In this context, universal access to healthcare assumes prime importance. However, healthcare delivery poses a significant challenge for policymakers in India. A severe lack of resources means that there is only one doctor per 1,700 citizens in India, well below the [...]
This video captures the highlights of the daylong NDTV Fortis CANCERTHON campaign telecasted on Sunday, Feb 8th, 2015. The initiative, focused on creating awareness on Cancer and raising funds to support treatment of children suffering with Cancer. This video talks about the affordable Cancer Care model at the Mazumdar Shaw Cancer Centre. Kiran Mazumdar Shaw [...]